These data insinuated that HCG11/miR-579-3p/MDM2 functioned as a ceRNA network to promote the progression of pancreatic carcinoma cells by inactivating Notch/Hes1 pathway. Here, HCG11 is linked to exocrine pancreatic carcinoma.